Evidence map›Paper›PMID 31890119›Full record

ArticleJournal of dental sciences2019

Therapeutic effects of caffeic acid phenethyl ester on alveolar bone loss in rats with endotoxin-induced periodontitis.

Alper Kızıldağ, Taner Arabacı, Mevlüt Albayrak, Ufuk Taşdemir, Erman Şenel, Mukaddes Dalyanoglu, Elif Demirci

Open access · goldAbstract read
In one paragraph

Article in Journal of dental sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alper KızıldağDepartment of Periodontology, Faculty of Dentistry, Pamukkale University, Denizli, Turkey.
Taner ArabacıDepartment of Periodontology, Faculty of Dentistry, Atatürk University, Erzurum, Turkey.
Mevlüt AlbayrakMedical Laboratory Department, Health Services Vocational Training School, Ataturk University, Erzurum, Turkey.
Ufuk TaşdemirDepartment of Maxillofacial Surgery, Faculty of Dentistry, Pamukkale University, Denizli, Turkey.
Erman ŞenelDepartment of Maxillofacial Surgery, Faculty of Dentistry, Pamukkale University, Denizli, Turkey.
Mukaddes DalyanogluDepartment of Physiology, Medical School, Pamukkale University, Denizli, Turkey.
Elif DemirciMedical Biology Department, Medical School, Ataturk University, Erzurum, Turkey.
Pamukkale University · TRAtatürk University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background/purposeCaffeic acid phenethyl ester (CAPE) is an antioxidant which is decreases the bone resorption and enhances the bone healing. The aim of this study was to investigate the effects of administering systemic CAPE on alveolar bone loss in rats with experimental periodontitis. MATERIALS AND

methodsThirty male Sprague Dawley rats were divided into three groups: control, endotoxin-induced periodontitis (EP), and EP treated with CAPE (EP-CAPE). Endotoxin was injected into the gingiva of test rats on days 1, 3, and 5, whereas saline was injected into the control rats. The EP-CAPE group received 10 mmol/kg/day CAPE intraperitoneally for 28 consecutive days. Saline was given in the control and EP groups in the same manner. At the end of the study, intracardiac blood samples were obtained, and the rats were sacrificed. Alveolar bone loss was analyzed with histometric measurements. The oxidative stress index (OSI) was used to evaluate the oxidative stress. The receptor activator of the nuclear factor kappa B ligand (RANKL) level was analyzed stereologically.

resultsCAPE administration significantly decreased the serum OSI and interleukin-1β levels. Alveolar bone loss was statistically higher in the EP group compared with the EP-CAPE group (

conclusionThis experimental study revealed that CAPE administration significantly prevented alveolar bone loss and stimulated periodontal tissue healing.

Indexed as

AntioxidantsOxidative stressPeriodontal diseasesReceptor activator of the nuclear factor kappa B ligand

Identifiers

PMID31890119
PMCPMC6921107
OpenAlexW2943842501

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.